Creation of a Bank of Fibroblast From Patients With Amyotrophic Lateral Sclerosis: Pilot Study (ALSCELL)

Pasteur Institute

Status: Completed

Conditions: Amyotrophic Lateral Sclerosis

Treatments: Procedure: skin biopsy

Study type: Interventional

Funder types: Industry

Identifiers

NCT01639391

2010-33

Details and patient eligibility

About

Patients with ALS will be included in the reference center for ALS in hospital La Pitié Salpêtrière, Paris.

The study proposes to investigate the pathophysiology of ALS by setting up a fibroblast bank for studying molecular, cellular and genetic parameters of the pathology.

iPS (induced pluripotent stem cells) and then differentiated cells will be generated.

The pathophysiology of ALS will be studied on the 3 types of cells (fibroblasts, iPS, differentiated cells).

Enrollment: 19 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients over 18 years old
• ALS sporadic or familial or unknown

Exclusion criteria

• known cutaneous disease not allowing the biopsy
• platelets less than 10 000/m3
• suspected or known xylocain allergy

Trial design

Primary purpose: Basic Science

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

19 participants in 1 patient group

patients

Experimental group

Treatment:

Procedure: skin biopsy